Total Payments
$23,271
2024 Payments
$4,189
Companies
84
Transactions
1,206
Medicare Patients
2,665
Medicare Billing
$885,467
Payment Breakdown by Category
Food & Beverage$21,955 (94.3%)
Consulting$888.75 (3.8%)
Education$260.16 (1.1%)
Other$166.34 (0.7%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $21,955 | 1,188 | 94.3% |
| Consulting Fee | $888.75 | 1 | 3.8% |
| Education | $260.16 | 5 | 1.1% |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $166.34 | 12 | 0.7% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| ABBVIE INC. | $3,200 | 141 | $0 (2024) |
| GENZYME CORPORATION | $1,793 | 66 | $0 (2023) |
| Teva Pharmaceuticals USA, Inc. | $1,535 | 110 | $0 (2024) |
| Amgen Inc. | $1,377 | 52 | $0 (2024) |
| Novartis Pharmaceuticals Corporation | $1,322 | 79 | $0 (2024) |
| UCB, Inc. | $1,056 | 53 | $0 (2024) |
| Alexion Pharmaceuticals, Inc. | $1,000 | 41 | $0 (2024) |
| Lundbeck LLC | $742.00 | 36 | $0 (2024) |
| Biogen, Inc. | $678.79 | 41 | $0 (2024) |
| Genentech USA, Inc. | $676.32 | 41 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $4,189 | 197 | ABBVIE INC. ($730.38) |
| 2023 | $3,458 | 194 | ABBVIE INC. ($741.21) |
| 2022 | $2,970 | 177 | ABBVIE INC. ($406.87) |
| 2021 | $2,839 | 101 | AbbVie Inc. ($1,213) |
| 2020 | $865.13 | 46 | SK Life Science, Inc. ($139.81) |
| 2019 | $3,421 | 178 | GENZYME CORPORATION ($795.55) |
| 2018 | $2,974 | 166 | GENZYME CORPORATION ($624.85) |
| 2017 | $2,554 | 147 | Allergan Inc. ($312.84) |
All Payment Transactions
1,206 individual payment records from CMS Open Payments — Page 1 of 49
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/13/2024 | Boston Scientific Corporation | WaveWriter Alpha Prime 16 (Device) | Food and Beverage | In-kind items and services | $20.83 | General |
| Category: WaveWriter Alpha_NMD | ||||||
| 12/12/2024 | Neurocrine Biosciences, Inc. | INGREZZA (Drug) | Food and Beverage | In-kind items and services | $23.24 | General |
| Category: Neuropsychiatry | ||||||
| 12/12/2024 | Lilly USA, LLC | EMGALITY (Drug) | Food and Beverage | In-kind items and services | $12.62 | General |
| Category: Neuroscience | ||||||
| 12/11/2024 | Alexion Pharmaceuticals, Inc. | ULTOMIRIS (Biological) | Food and Beverage | In-kind items and services | $25.90 | General |
| Category: Rare Disease | ||||||
| 12/10/2024 | UCB, Inc. | Briviact (Drug) | Food and Beverage | In-kind items and services | $24.10 | General |
| Category: Neurology | ||||||
| 12/10/2024 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $16.02 | General |
| Category: PAIN | ||||||
| 12/05/2024 | Amgen Inc. | UPLIZNA (Biological) | Food and Beverage | In-kind items and services | $27.68 | General |
| Category: Inflammation/Rare Disease | ||||||
| 12/04/2024 | ABBVIE INC. | UBRELVY (Drug), QULIPTA | Food and Beverage | In-kind items and services | $24.81 | General |
| Category: NEUROSCIENCE | ||||||
| 12/04/2024 | UCB, Inc. | Nayzilam (Drug) | Food and Beverage | In-kind items and services | $23.86 | General |
| Category: Neurology | ||||||
| 12/04/2024 | UCB, Inc. | Briviact (Drug) | Food and Beverage | In-kind items and services | $12.80 | General |
| Category: Neurology | ||||||
| 12/03/2024 | ABBVIE INC. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $24.15 | General |
| Category: BOTOX THERAPEUTIC | ||||||
| 12/02/2024 | UCB, Inc. | Briviact (Drug) | Food and Beverage | In-kind items and services | $38.33 | General |
| Category: Neurology | ||||||
| 11/25/2024 | ABBVIE INC. | BOTOX (Biological), QULIPTA | Food and Beverage | In-kind items and services | $19.36 | General |
| Category: BOTOX THERAPEUTIC | ||||||
| 11/25/2024 | Alexion Pharmaceuticals, Inc. | ULTOMIRIS (Biological) | Food and Beverage | In-kind items and services | $18.82 | General |
| Category: Rare Disease | ||||||
| 11/22/2024 | ABBVIE INC. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $19.55 | General |
| Category: NEUROSCIENCE | ||||||
| 11/20/2024 | UCB, Inc. | Briviact (Drug) | Food and Beverage | In-kind items and services | $22.76 | General |
| Category: Neurology | ||||||
| 11/19/2024 | TG Therapeutics, Inc. | BRIUMVI (Drug) | Food and Beverage | In-kind items and services | $27.54 | General |
| Category: Immunology | ||||||
| 11/18/2024 | Teva Pharmaceuticals USA, Inc. | Austedo XR (Drug) | Food and Beverage | In-kind items and services | $19.22 | General |
| Category: Central Nervous System | ||||||
| 11/13/2024 | Lundbeck LLC | VYEPTI (Biological) | Food and Beverage | Cash or cash equivalent | $24.83 | General |
| Category: NEUROLOGY | ||||||
| 11/07/2024 | Lilly USA, LLC | KISUNLA (Drug) | Food and Beverage | Cash or cash equivalent | $120.89 | General |
| Category: Neuroscience | ||||||
| 11/07/2024 | ABBVIE INC. | QULIPTA (Drug), UBRELVY | Food and Beverage | In-kind items and services | $21.83 | General |
| Category: NEUROSCIENCE | ||||||
| 11/07/2024 | Teva Pharmaceuticals USA, Inc. | AJOVY (Biological) | Food and Beverage | In-kind items and services | $20.72 | General |
| Category: Central Nervous System | ||||||
| 11/06/2024 | Celgene Corporation | ZEPOSIA (Drug) | Food and Beverage | Cash or cash equivalent | $27.45 | General |
| Category: Neuroscience | ||||||
| 10/29/2024 | Neurocrine Biosciences, Inc. | INGREZZA (Drug) | Food and Beverage | In-kind items and services | $20.55 | General |
| Category: Neuropsychiatry | ||||||
| 10/29/2024 | Neurocrine Biosciences, Inc. | INGREZZA (Drug) | Food and Beverage | In-kind items and services | $1.92 | General |
| Category: Neuropsychiatry | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 15 | 532 | 24,645 | $922,897 | $346,699 |
| 2022 | 13 | 635 | 16,268 | $532,705 | $130,695 |
| 2021 | 15 | 610 | 16,233 | $574,574 | $135,466 |
| 2020 | 26 | 888 | 22,979 | $956,901 | $272,606 |
Total Patients
2,665
Total Services
80,125
Medicare Billing
$885,467
Procedure Codes
69
All Medicare Procedures & Services
69 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| J2323 | Injection, natalizumab, 1 mg | Office | 2023 | 11 | 6,900 | $241,500 | $132,736 | 55.0% |
| J1561 | Injection, immune globulin, (gamunex-c/gammaked), non-lyophilized (e.g., liquid), 500 mg | Office | 2023 | 19 | 2,750 | $247,500 | $105,442 | 42.6% |
| J0585 | Injection, onabotulinumtoxina, 1 unit | Office | 2023 | 23 | 12,530 | $162,890 | $59,256 | 36.4% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 149 | 149 | $56,620 | $15,753 | 27.8% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 108 | 127 | $27,940 | $10,136 | 36.3% |
| 64615 | Injection of chemical for paralysis of facial and neck nerve muscles on both sides of face | Office | 2023 | 23 | 63 | $35,280 | $6,445 | 18.3% |
| 96413 | Administration of chemotherapy into vein, 1 hour or less | Office | 2023 | 25 | 40 | $20,400 | $3,718 | 18.2% |
| 96365 | Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less | Office | 2023 | 40 | 68 | $15,504 | $3,063 | 19.8% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 21 | 47 | $7,050 | $2,844 | 40.3% |
| 70553 | Mri scan of brain before and after contrast | Office | 2023 | 18 | 18 | $40,230 | $2,689 | 6.7% |
| 70551 | Mri scan of brain without contrast | Office | 2023 | 25 | 25 | $49,500 | $2,507 | 5.1% |
| 96366 | Infusion into a vein for therapy, prevention, or diagnosis, each additional hour | Office | 2023 | 20 | 53 | $8,798 | $778.50 | 8.8% |
| 96375 | Injection of additional new drug or substance into vein | Office | 2023 | 18 | 61 | $6,100 | $627.07 | 10.3% |
| A9585 | Injection, gadobutrol, 0.1 ml | Office | 2023 | 18 | 1,750 | $2,625 | $436.24 | 16.6% |
| J2930 | Injection, methylprednisolone sodium succinate, up to 125 mg | Office | 2023 | 14 | 64 | $960.00 | $268.38 | 28.0% |
| J0585 | Injection, onabotulinumtoxina, 1 unit | Office | 2022 | 21 | 13,365 | $173,745 | $61,222 | 35.2% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 217 | 217 | $82,460 | $25,059 | 30.4% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 181 | 231 | $50,820 | $20,468 | 40.3% |
| 64615 | Injection of chemical for paralysis of facial and neck nerve muscles on both sides of face | Office | 2022 | 21 | 69 | $38,640 | $7,208 | 18.7% |
| 70551 | Mri scan of brain without contrast | Office | 2022 | 53 | 53 | $104,940 | $4,912 | 4.7% |
| 95816 | Measurement of brain wave activity (eeg), awake and drowsy | Office | 2022 | 11 | 11 | $7,920 | $3,221 | 40.7% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 39 | 46 | $6,900 | $2,630 | 38.1% |
| 70553 | Mri scan of brain before and after contrast | Office | 2022 | 16 | 17 | $37,995 | $2,429 | 6.4% |
| 99233 | Follow-up hospital inpatient care per day, typically 35 minutes | Facility | 2022 | 15 | 18 | $3,726 | $1,433 | 38.5% |
| 72148 | Mri scan of lower spinal canal without contrast | Office | 2022 | 12 | 12 | $18,888 | $1,035 | 5.5% |
About Dr. William Ferrell, M.D
Dr. William Ferrell, M.D is a Neurology healthcare provider based in Raleigh, North Carolina. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 07/06/2006. The National Provider Identifier (NPI) number assigned to this provider is 1740212562.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. William Ferrell, M.D has received a total of $23,271 in payments from pharmaceutical and medical device companies, with $4,189 received in 2024. These payments were reported across 1,206 transactions from 84 companies. The most common payment nature is "Food and Beverage" ($21,955).
As a Medicare-enrolled provider, Ferrell has provided services to 2,665 Medicare beneficiaries, totaling 80,125 services with total Medicare billing of $885,467. Data is available for 4 years (2020–2023), covering 69 distinct procedure/service records.
Ad
Practice Information
- Specialty Neurology
- Location Raleigh, NC
- Active Since 07/06/2006
- Last Updated 04/01/2021
- Taxonomy Code 2084N0400X
- Entity Type Individual
- NPI Number 1740212562
Products in Payments
- UBRELVY (Drug) $1,931
- Aimovig (Biological) $1,169
- AUBAGIO (Drug) $962.87
- NURTEC ODT (Drug) $822.64
- LEMTRADA (Drug) $788.01
- Briviact (Drug) $736.93
- QULIPTA (Drug) $692.40
- BOTOX (Biological) $633.06
- VALTOCO (Drug) $590.51
- KESIMPTA (Drug) $581.94
- OCREVUS (Biological) $532.97
- VYEPTI (Biological) $532.39
- SOLIRIS (Drug) $466.60
- AIMOVIG (Biological) $368.76
- AJOVY (Drug) $358.86
- Trudhesa (Drug) $356.87
- APTIOM (Drug) $343.29
- INGREZZA (Drug) $336.31
- AUSTEDO (Drug) $336.22
- AJOVY (Biological) $312.47
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Neurology Doctors in Raleigh
John Scagnelli, M.d, M.D
Neurology — Payments: $434,945
Neurology $434,945
Dr. Tibor Becske, M.d, M.D
Neurology — Payments: $387,165
Neurology $387,165
Dr. Keith Hull, M.d, M.D
Neurology — Payments: $140,830
Neurology $140,830
Dr. Casey Jeffreys, M.d, M.D
Neurology — Payments: $70,215
Neurology $70,215
John Collins, M.d, M.D
Neurology — Payments: $25,595
Neurology $25,595
Dr. Kenneth Carnes, M.d, M.D
Neurology — Payments: $23,277
Neurology $23,277